Given that CXCR4 is an important therapeutic target for the treatment of cancer and immune-related diseases, further identification of CXCR4 heteromers and comprehensive understanding of their physiological relevance will provide valuable insights for the advancement of future therapeutics. This evidence concerns the gene CXCR4 and cancer.